Status:
COMPLETED
Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis
Lead Sponsor:
Mayo Clinic
Conditions:
Thumb Carpometacarpal Joint Osteoarthritis
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to investigate a case series of patients treated with Platelet-rich plasma for thumb carpometacarpal joint osteoarthritis. Carpometacarpal arthritis is a highly prevalent ...
Detailed Description
The first carpometacarpal (CMC) joint at the base of the thumb is one of the most commonly affected joints by osteoarthritis (OA), with a prevalence ranging from 15-36% in females and 5-11% in males. ...
Eligibility Criteria
Inclusion
- \- Patients who previously underwent PRP injection of their first CMC joint.
Exclusion
- \- Individuals less than 18 years of age.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 2 2021
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04886349
Start Date
October 1 2020
End Date
April 2 2021
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905